161890.KO Korea Kolmar
- Market cap
- KRW 2.86T
- P/E
- 14.4x
- P/B
- 2.71x
- ROE
- 21.6%
- Dividend yield
- 0.79%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 161890.KO undervalued?
Graham number161890.KO trades 31.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Korea Kolmar fundamental analysis
No fundamental analysis for Korea Kolmar yet.
Korea Kolmar stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Korea Kolmar
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers skincare cosmetic products, including toners, lotions, ampoules, essences, creams, mask sheets, mask packs, and lip balms; fragrance products, such as perfumes, and cleansing products; body and hair products; and color cosmetic products comprising makeup bases, primers, foundation and concealers, cushion foundations, and mascaras. The comp…
Full company profileKorea Kolmar financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Korea Kolmar annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 667B | 822B | 1.36T | 1.54T | 1.32T | 1.59T | 1.87T | 2.16T | 2.45T | 2.72T | 3.18T |
| Gross Profit | 154B | 178B | 357B | 432B | 426B | 428B | 469B | 578B | 699B | 791B | 914B |
| Operating Income | 73.4B | 67.0B | 90.0B | 118B | 122B | 84.3B | 73.4B | 137B | 194B | 240B | 378B |
| EBITDA | - | 85.2B | 131B | 177B | 321B | 156B | 125B | 173B | 278B | 355B | 503B |
| Net Income | 53.1B | 47.3B | 42.3B | 29.1B | 160B | 35.8B | -22.0B | 5.19B | 90.1B | 125B | 216B |
| EPS | - | 2,239 | 1,893 | 1,270 | 7,005 | 1,565 | -961 | 227 | 3,816 | 5,299 | 9,150 |
| Balance Sheet | |||||||||||
| Total Assets | 493B | 669B | 2.19T | 2.40T | 2.49T | 2.61T | 2.93T | 3.01T | 3.13T | 3.46T | 3.63T |
| Total Liabilities | 205B | 336B | 1.38T | 1.55T | 1.49T | 1.25T | 1.46T | 1.59T | 1.62T | 1.79T | 1.86T |
| Shareholders' Equity | 270B | 305B | 438B | 471B | 624B | 684B | 664B | 649B | 793B | 910B | 1.00T |
| Cash & Short-term Investments | 26.9B | 14.3B | 76.5B | 119B | 377B | 191B | 220B | 171B | 142B | 225B | 177B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 38.2B | 5.39B | 62.8B | 165B | 121B | -3.12B | 90.8B | 112B | 215B | 291B | 157B |
| Capital Expenditure | 45.7B | 68.6B | 79.2B | 74.0B | 123B | 42.2B | 38.7B | 125B | 261B | 180B | 96.6B |
| Free Cash Flow | - | -71.9B | -21.4B | 89.5B | -1.59B | -54.5B | 33.4B | -12.5B | -45.1B | 112B | 60.6B |
| Ratios | |||||||||||
| ROE | 19.7% | 15.5% | 9.7% | 6.2% | 25.7% | 5.2% | -3.3% | 0.8% | 11.4% | 13.7% | 21.6% |
| ROA | 10.8% | 7.1% | 1.9% | 1.2% | 6.4% | 1.4% | -0.7% | 0.2% | 2.9% | 3.6% | 6.0% |
| Net Profit Margin | 8.0% | 5.8% | 3.1% | 1.9% | 12.1% | 2.3% | -1.2% | 0.2% | 3.7% | 4.6% | 6.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Korea Kolmar dividends
- Dividend yield
- 0.79%
- Forward dividend
- 864.00 KRW
- Payout ratio
- 18.1%
- Ex-dividend date
- Mar 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 22.6B | 959 | 18.1% |
| 2024 | KRW 19.4B | 821 | 21.5% |
| 2023 | KRW 16.6B | 726 | 319.9% |
| 2022 | KRW 14.8B | 649 | - |
| 2021 | KRW 7.89B | 345 | 22.0% |
| 2020 | KRW 7.55B | 330 | 4.7% |
| 2019 | KRW 7.37B | 322 | 25.4% |
| 2018 | KRW 6.33B | 283 | 15.0% |
| 2017 | KRW 6.22B | 295 | 13.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Korea Kolmar
- Insiders 38.32%
- Institutions 26.30%
- Public & others 35.39%
- Shares outstanding 23.6M
- Free float 14.6M
Korea Kolmar company profile
- Company name
- Korea Kolmar
- Ticker
- 161890.KO
- ISIN
- KR7161890009
- Exchange
- Korea Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 1,451
- Fiscal year end
- December
- Address
- 12-11 Doekgogae-gil, Sejong City, South Korea
- Phone
- 82 4 4860 0532
- Website
- kolmar.co.kr
About Korea Kolmar
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers skincare cosmetic products, including toners, lotions, ampoules, essences, creams, mask sheets, mask packs, and lip balms; fragrance products, such as perfumes, and cleansing products; body and hair products; and color cosmetic products comprising makeup bases, primers, foundation and concealers, cushion foundations, and mascaras. The company also provides powder base products, such as eye shadows, powder pacts, highlighters, blushers, shadings, loose powders, jelly powders, wet powders, multi-color concurrent forming, gradations, marble teracotas, hair cushions, essence powders, bubble salts, eyebrow pencils, highlighters, etc.; and oil & emulsification base products, including lip sticks, lip balms, lip glosses, tints, essence pacts, stick foundations, sun sticks, skin covers, gel eyeliners, marble essence pacts, core sticks, two-tone sticks, marble sticks, serum sticks, eye sticks, balms, concealers, etc. In addition, it offers PLATIT147, a health and beauty production platform. Further, the company engages in the real estate rental business and manufacturing of plastic molded containers. Kolmar Korea Co., Ltd. was founded in 1990 and is headquartered in Sejong City, South Korea.
Korea Kolmar management
7- Mr. Sang-Geun HanVP & Chairman · born 1973
- Mr. Hyun-Gyu ChoiCEO, President & Director · born 1960
- Mr. Yi-Pyo HongSenior MD of KMB & Director · born 1966
- Mr. Philippe WarneryGlobal Chief Commercial Officer
- Mr. George RiveraChief Science Officer of Kolmar North American subsidiaries
- Mr. Inki ParkHead of the R&D Center for North America
- Mr. Yongchul HurCEO of Kolmar Laboratories, Kolmar USA & CEO of North American subsidiaries